Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chujie Bai

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
World Journal of Surgical Oncology|May 13, 2026
The efficacy and predictive value of <sup>99m</sup>Tc-rituximab for sentinel lymph node biopsy in acral melanoma patientsRuifeng Xue, Zhiyan Liu, Zhichao Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II TrialZhichao Tan, Yan Wu, Zhengfu Fan, et al.
BMC Cancer|March 15, 2024
Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survivalDan Zhao, Fang Zhou, Weixin Liu, et al.
Journal for Immunotherapy of Cancer|January 17, 2025
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trialZhichao Tan, Yan Wu, Zhengfu Fan, et al.
Cell Reports. Medicine|March 7, 2025
Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomasTian Gao, Xinyu He, Junyi Wang, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
World Journal of Surgical Oncology|May 13, 2026
The efficacy and predictive value of <sup>99m</sup>Tc-rituximab for sentinel lymph node biopsy in acral melanoma patientsRuifeng Xue, Zhiyan Liu, Zhichao Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II TrialZhichao Tan, Yan Wu, Zhengfu Fan, et al.
BMC Cancer|March 15, 2024
Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survivalDan Zhao, Fang Zhou, Weixin Liu, et al.
Journal for Immunotherapy of Cancer|January 17, 2025
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trialZhichao Tan, Yan Wu, Zhengfu Fan, et al.
Cell Reports. Medicine|March 7, 2025
Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomasTian Gao, Xinyu He, Junyi Wang, et al.
Pageof 3